This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Jskbiomed Inc., Other. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Innovations by Jin Woo Jeon
Introduction
Jin Woo Jeon is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. His work focuses on enhancing the efficiency and safety of drug administration methods.
Latest Patents
One of his latest inventions is the microjet drug injection device equipped with a backflow prevention valve. This innovative device comprises an upper housing, a lower housing, a partition, and a backflow prevention valve that features a slit allowing the drug to move only towards the injection nozzle. This design aims to improve the precision and safety of drug delivery.
Another significant patent is the needleless drug delivery system. This system enhances the durability of a membrane that partitions a space for drug filling. By reinforcing weak portions of the membrane or forming a double membrane, this invention addresses common issues associated with traditional needle-based delivery methods.
Career Highlights
Jin Woo Jeon has worked with various companies, including Jskbiomed Inc. His experience in the industry has allowed him to develop practical solutions that address real-world challenges in drug delivery.
Collaborations
Throughout his career, Jin Woo Jeon has collaborated with talented individuals such as Jung Kook Kim and Seung Dal Seo. These partnerships have contributed to the advancement of his innovative projects.
Conclusion
Jin Woo Jeon's contributions to the field of drug delivery systems demonstrate his commitment to innovation and improving healthcare solutions. His patents reflect a deep understanding of the challenges in drug administration, paving the way for safer and more effective methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile